<SEC-DOCUMENT>0001193125-22-118164.txt : 20220426
<SEC-HEADER>0001193125-22-118164.hdr.sgml : 20220426
<ACCEPTANCE-DATETIME>20220425185554
ACCESSION NUMBER:		0001193125-22-118164
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20220424
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220426
DATE AS OF CHANGE:		20220425

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Zevia PBC
		CENTRAL INDEX KEY:			0001854139
		STANDARD INDUSTRIAL CLASSIFICATION:	BOTTLED & CANNED SOFT DRINKS CARBONATED WATERS [2086]
		IRS NUMBER:				862862492
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40630
		FILM NUMBER:		22851177

	BUSINESS ADDRESS:	
		STREET 1:		15821 VENTURA BLVD.
		STREET 2:		SUITE 145
		CITY:			ENCINO
		STATE:			CA
		ZIP:			91436
		BUSINESS PHONE:		(310) 202-7000

	MAIL ADDRESS:	
		STREET 1:		15821 VENTURA BLVD.
		STREET 2:		SUITE 145
		CITY:			ENCINO
		STATE:			CA
		ZIP:			91436
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d287617d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:zvia="http://www.zevia.com/20220424" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2022-04-24_to_2022-04-24">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2022-04-24_to_2022-04-24">0001854139</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="zvia-20220424.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2022-04-24_to_2022-04-24"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001854139</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-04-24</xbrli:startDate> <xbrli:endDate>2022-04-24</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, D.C. 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2022-04-24_to_2022-04-24">8-K</ix:nonNumeric></span></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">PURSUANT TO SECTION 13 OR 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">OF THE SECURITIES EXCHANGE ACT OF 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of Earliest Event Reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2022-04-24_to_2022-04-24" format="ixt:datemonthdayyearen">April 24, 2022</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2022-04-24_to_2022-04-24">ZEVIA PBC</ix:nonNumeric> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact Name of Registrant as Specified in Its Charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2022-04-24_to_2022-04-24" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2022-04-24_to_2022-04-24">001-40630</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2022-04-24_to_2022-04-24">86-2862492</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(State or Other Jurisdiction<br />of Incorporation)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Commission<br />File Number)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(IRS Employer<br />Identification No.)</span></td></tr></table> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:49%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2022-04-24_to_2022-04-24">15821 Ventura Blvd.</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2022-04-24_to_2022-04-24">Suite 145</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2022-04-24_to_2022-04-24">Encino</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2022-04-24_to_2022-04-24">CA</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2022-04-24_to_2022-04-24">91436</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of Principal Executive Offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2022-04-24_to_2022-04-24">(855)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2022-04-24_to_2022-04-24">469-3842</ix:nonNumeric></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s Telephone Number, Including Area Code)</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Former Name or Former Address, if Changed Since Last Report: N/A</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2022-04-24_to_2022-04-24" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2022-04-24_to_2022-04-24" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2022-04-24_to_2022-04-24" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2022-04-24_to_2022-04-24" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section 12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br />Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange<br />on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2022-04-24_to_2022-04-24">Class&#160;A common stock, par value $0.001 per share</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2022-04-24_to_2022-04-24">ZVIA</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2022-04-24_to_2022-04-24" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#160;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;&#160;240.12b-2</span> of this chapter).</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2022-04-24_to_2022-04-24" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act. <ix:nonNumeric name="dei:EntityExTransitionPeriod" contextRef="duration_2022-04-24_to_2022-04-24" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#160;5.02&#160;&#160;&#160;&#160;Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">(b) Departing Officers </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On April&#160;25, 2022, Zevia PBC (the &#8220;Company&#8221;) announced that William &#8220;Bill&#8221; D. Beech, Chief Financial Officer, will step down as CFO effective May&#160;3, 2022, and depart from the Company on May&#160;6, 2022. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, as previously reported, Harry &#8220;Hank&#8221; M. Margolis, Chief Operating Officer, will be retiring from the Company. He will step down from his position effective June&#160;13, 2022 and will retire effective June&#160;24, 2022. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">(c) Officer Appointments </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On April&#160;24, 2022, the Company&#8217;s Board of Directors (the &#8220;Board&#8221;) appointed Denise D. Beckles, 57, to serve as Chief Financial Officer, effective May&#160;3, 2022 (the &#8220;Beckles Start Date&#8221;), and Quincy B. Troupe, 55, to serve as Chief Operating Officer, effective June&#160;13, 2022 (the &#8220;Troupe Start Date&#8221;). Mr.&#160;Troupe currently serves on the Board and will step down as a director effective as of the Troupe Start Date. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Denise D. Beckles as Chief Financial Officer </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to joining the Company, Ms.&#160;Beckles most recently served as Chief Financial Officer of Sol de Janeiro, a skincare products company, where she was responsible for overseeing the finance, IT, legal, HR, operations and supply chain functions from July 2020 to 2022. Prior to joining Sol de Janeiro, Ms.&#160;Beckles served as the Chief Financial Officer for Revolution Foods, a healthy meal company, where she was responsible for overseeing the finance, investor relations, IT, and business analytics and insights functions from September 2018 to July 2019. Previously, Ms.&#160;Beckles held three roles at Godiva Chocolatier, Inc., a multinational gourmet chocolate company, including Chief Financial Officer of Godiva North America and Chief Strategy Officer of Global Business from 2016 to 2018 and Global Head of Financial Planning and Analysis during 2015. Ms.&#160;Beckles also held various senior leadership roles in finance, strategy and business development with Pernod Ricard USA, LLC including Vice President, Business Development and Strategy from 2014 to 2015, Vice President, Finance and Strategy (Wines and Champagnes) from 2012 to 2014, and Vice President, Treasurer from 2010 to 2012. Ms.&#160;Beckles earned both a Master of Business Administration in Accounting, Finance and Business Management and a Bachelor of Science in Accounting and Finance from Clarkson University. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There are no family relationships between Ms.&#160;Beckles and any director or executive officer of the Company, and she has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation <span style="white-space:nowrap">S-K.</span> </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Description of Agreements with Ms.&#160;Beckles </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with her appointment, the Company and Ms.&#160;Beckles entered into a Letter Agreement (the &#8220;Beckles Letter Agreement&#8221;), which sets forth the terms of Ms.&#160;Beckles&#8217; employment with the Company as Chief Financial Officer, effective as of the Beckles Start Date. The Beckles Letter Agreement provides for (i)&#160;an annual base salary of $400,000, (ii) a target annual bonus equal to 75% of base salary, <span style="white-space:nowrap">pro-rated</span> for 2022, (iii) a $250,000 <span style="white-space:nowrap">sign-on</span> bonus, payable <span style="white-space:nowrap">one-half</span> within 30 days of the Beckles Start Date and <span style="white-space:nowrap">one-half</span> after six months&#8217; employment, and subject to repayment in the event Ms.&#160;Beckles voluntarily resigns or is terminated for cause within the first 12 months of employment, and (iv)&#160;a relocation allowance of $100,000, grossed up for taxes. In addition, Ms.&#160;Beckles is eligible to receive a target long-term incentive award of $850,000, subject to approval by the Board or the Compensation Committee of the Board, which will consist 50% of options and 50% of time-vested restricted stock units that each vest in four equal annual installments. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, Ms.&#160;Beckles entered into the Company&#8217;s standard severance agreement (the &#8220;Beckles Severance Agreement&#8221;), which provides for severance benefits in the event Ms.&#160;Beckles is terminated by the Company without Cause (as defined in the Beckles Severance Agreement) or resigns for Good Reason (as defined in the Beckles Severance Agreement) (each a &#8220;Qualifying Termination&#8221;). Subject to execution of a release of claims in favor of the Company, upon a Qualifying Termination, Ms.&#160;Beckles will be eligible to receive the following severance benefits: (i) 12 months of base salary payable in installments (or, if the Qualifying Termination occurs within 18 months following a change in control of the Company, a lump sum payment equal to the sum of Ms.&#160;Beckles&#8217;s annual base salary and target annual bonus), (ii) partially subsidized COBRA premiums for the <span style="white-space:nowrap">12-month</span> period following termination, and (iii)&#160;any earned but unpaid annual bonus for the year prior to the year of termination payable at the time bonuses are paid to other executives. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This summary of the Beckles Letter Agreement and Beckles Severance Agreement does not purport to be complete and is subject to and qualified in its entirety by reference to the text of the Beckles Letter Agreement and Beckles Severance Agreement filed as Exhibits 10.1 and 10.2 to this Current Report on Form <span style="white-space:nowrap">8-K,</span> which are incorporated herein by reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ms.&#160;Beckles has also entered into the Company&#8217;s employment, confidential information, and invention assignment agreement, which includes customary confidentiality, <span style="white-space:nowrap">non-disclosure,</span> employee <span style="white-space:nowrap">non-solicitation</span> and invention assignment covenants, the Company&#8217;s mutual arbitration agreement, and the Company&#8217;s director and officer indemnification agreement. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Quincy B. Troupe as Chief Operating Officer </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&#160;Troupe has served as a member of our Board since the completion of our initial public offering in July 2021. Mr.&#160;Troupe has served as Senior Vice President of Supply Chain at The Boston Beer Company (&#8220;Boston Beer&#8221;), a beer brewery, from January 2016 to April&#160;1, 2022. At Boston Beer, he led a multi-year capacity and capability expansion program that enabled Boston Beer to more than double in size and become one of the fastest growing beverage companies in the world, and he contributed to the significant annual savings to help fuel Boston Beer&#8217;s continued growth. Mr.&#160;Troupe is a <span style="white-space:nowrap">25-year</span> veteran of the consumer packaged goods, food and beverage industry, and has served in a variety of roles including in manufacturing, engineering, supply chain strategy and planning, human resources and enterprise shared services. From 2010 to 2015, he served as Vice President of Supply Chain and subsequently, Vice President of Manufacturing and Supply Chain Strategy, for the Pepperidge Farm brand at Campbell Soup Company, a packaged food company. Prior to Campbell Soup, from 1997 to 2010, Mr.&#160;Troupe served in various roles at Mars, Incorporated, a packaged food company, including most recently as Director of Mars Chocolate Innovation and Operating Systems. From 1994 to 1997, Mr.&#160;Troupe served as Shift Site Manager and subsequently, Process and Packaging Area Manager, at Abbott Laboratories, a medical device company. Mr.&#160;Troupe earned a Bachelor of Science in Mechanical Engineering from the State University of New York at Stony Brook and completed the Executive General Management Program at the Harvard Business School. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There are no family relationships between Mr.&#160;Troupe and any director or executive officer of the Company, and he has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation <span style="white-space:nowrap">S-K.</span> </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Description of Agreements with Mr.&#160;Troupe </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with his appointment, the Company and Mr.&#160;Troupe entered into a Letter Agreement (the &#8220;Troupe Letter Agreement&#8221;), which sets forth the terms of Mr.&#160;Troupe&#8217;s employment with the Company as Chief Operating Officer, effective as of the Troupe Start Date. The Troupe Letter Agreement provides for (i)&#160;an annual base salary of $385,000, (ii) a target annual bonus equal to 75% of base salary, <span style="white-space:nowrap">pro-rated</span> for 2022, and (iii)&#160;a $100,000 <span style="white-space:nowrap">sign-on</span> bonus, payable <span style="white-space:nowrap">one-half</span> within 30 days of his start date and <span style="white-space:nowrap">one-half</span> after six months&#8217; employment and subject to repayment in the event Mr.&#160;Troupe voluntarily resigns or is terminated for cause within the first 12 months of employment. In addition, Mr.&#160;Troupe is eligible to receive a target long-term incentive award of $650,000, subject to approval by the Board or the Compensation Committee of the Board, which will consist 50% of options and 50% of time-vested restricted stock units that each vest in four equal annual installments. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, Mr.&#160;Troupe entered into the Company&#8217;s standard severance agreement (the &#8220;Troupe Severance Agreement&#8221;). The Troupe Severance Agreement provides for the same severance benefits described above with respect to the Beckles Severance Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This summary of the Troupe Letter Agreement and Troupe Severance Agreement does not purport to be complete and is subject to and qualified in its entirety by reference to the text of the Troupe Letter Agreement and Troupe Severance Agreement filed as Exhibits 10.3 and 10.4 to this Current Report on Form <span style="white-space:nowrap">8-K,</span> which are incorporated herein by reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&#160;Troupe has also entered into the Company&#8217;s employment, confidential information, and invention assignment agreement, which includes customary confidentiality, <span style="white-space:nowrap">non-disclosure,</span> employee <span style="white-space:nowrap">non-solicitation</span> and invention assignment covenants, and the Company&#8217;s mutual arbitration agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further information about Ms.&#160;Beckles and Mr.&#160;Troupe and their appointments as Chief Financial Officer and Chief Operating Officer, respectively, are included in the Company&#8217;s press release issued on April&#160;25, 2022, which is attached as Exhibit 99.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and is incorporated herein by reference. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#160;9.01 &#160;&#160;&#160;&#160;Financial Statements and Exhibits. </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:7%"></td>
<td style="width:90%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(d)&#160;Exhibits<span style="font-weight:bold">.</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">Exhibit&#160;10.1</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="d287617dex101.htm">Letter Agreement between the Company and Denise D. Beckles </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">Exhibit 10.2</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="d287617dex102.htm">Severance Agreement between the Company and Denise D. Beckles </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">Exhibit 10.3</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="d287617dex103.htm">Letter Agreement between the Company and Quincy B. Troupe </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">Exhibit 10.4</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="d287617dex104.htm">Severance Agreement between the Company and Quincy B. Troupe </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">Exhibit 99.1</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="d287617dex991.htm">Zevia PBC Press Release dated April&#160;25, 2022 </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">Exhibit 104</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data file (embedded within the Inline XBRL document)</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:47%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:46%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">ZEVIA PBC</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Date: April&#160;25, 2022</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Lorna R. Simms</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Name: Lorna R. Simms</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Title: &#160;&#160;SVP, General Counsel and Corporate Secretary</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d287617dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g287617dsp06.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">March&nbsp;11, 2022 </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Denise D. Beckles </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Re: <B>Offer of Employment by Zevia PBC</B>
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Denise,&nbsp;&nbsp;&nbsp;&nbsp; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I am very pleased to
confirm our offer to you of employment with Zevia PBC (the &#147;<B><I>Company</I></B>&#148;). Your estimated start date will be <B>May</B><B></B><B>&nbsp;1, 2022</B> or such other day as is mutually agreed upon. This offer and your employment
relationship will be subject to the terms and conditions in this letter. The Company reserves the right to modify job titles, reporting structures, wages and benefits from time to time as it deems necessary and appropriate. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">You will report to the <B>Chief Executive Officer</B>. Your job title will be <B>Chief Financial Officer.</B>
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As a regular full-time employee, you will be paid on a semi-monthly basis at an annual rate of <B>$400,000
</B>less payroll deductions and all required withholdings. The position is classified as exempt from the overtime provisions of state and federal law, which means you will not be paid overtime compensation. Your position will be subject to job
performance reviews. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="14%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In addition to your base pay, you will be entitled to receive a <B>$250,000</B> cash <FONT
STYLE="white-space:nowrap">sign-on</FONT> bonus payable in two equal installments of <B>50%</B> on <B>within <FONT STYLE="white-space:nowrap">30-days</FONT></B> from hire date, and <B>50%</B> at <B><FONT STYLE="white-space:nowrap">6-months</FONT>
from hire date</B>, less payroll deductions and all required withholdings, in the payroll period following your completion of six months of continued employment with the Company. The bonus will be subject to applicable supplemental taxation at the
federal and/or state levels(s) and will be subject to repayment in full in the event that you voluntarily resign your employment or are terminated for Cause (as defined in the Severance Agreement) within your first 12 months of employment.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="14%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">You will also be eligible to receive an allowance of <B>$100,000, </B>grossed up for taxes<B>, </B>for moving
expenses at the time of your relocation to California. The allowance will be paid via payroll on your first payroll check after relocation. The 2017 federal tax reform law suspended the previous income exclusion and reimbursements for an
employee&#146;s moving expenses that are incurred between January&nbsp;1, 2018, through December&nbsp;31, 2025, are taxable to the employee through December&nbsp;31, 2025 </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">You will also be eligible to earn discretionary merit-based compensation and the Company reserves the right to
modify its plan for such potential additional compensation as circumstances change. Subject to you continuing employment with the Company through the bonus earning date, you will be eligible to earn a bonus upon your achieving certain milestones
that will be determined by the Company&#146;s Board of Directors. Your current merit-based compensation has an annual target of <B>75% of your annual salary</B> (subject to a <FONT STYLE="white-space:nowrap">pro-rata</FONT> amount based on hired
date). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15821 Ventura Boulevard,
Suite 145 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Encino, California 91436 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">V40012019 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g287617dsp06.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to the approval of the Company&#146;s Compensation Committee of the Board of Directors, you will be
eligible to receive an annual long-term incentive (LTI) program award valued at <B>$850,000</B> per year, consisting of 50% stock options and 50% time-vested restricted stock units (RSUs) under the Zevia PBC 2021 Equity Incentive Plan the
(&#147;<B><I>Plan</I></B>&#148;) with vesting to occur in <FONT STYLE="white-space:nowrap">one-fourth</FONT> installments on each of the first four anniversaries of the grant date as long as you are continuously employed by the Company through each
anniversary date. You acknowledge that the LTI program and award amount will be formally approved by the Company&#146;s Compensation Committee of the Board of Directors on or before the end of the Company&#146;s first quarter of fiscal year 2022.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">We are pleased to share that your benefit details, vacation, sick/personal days, and Company paid holidays will
be reviewed during your onboarding process, as well as included in the Employee Handbook referenced in this offer letter. You will have the opportunity to review the plans in detail, along with having access to your benefit information via your
employee online portal. Benefits and perks are subject to change during open enrollment, and as deemed appropriate by the Company, at any time. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Because we are dealing with inventions and proprietary information, we must take care that our employees do not
have any unusual incidents in their past which might adversely affect our brand&#146;s reputation and our consumer&#146;s trust in us. <B>This offer is contingent upon the satisfactory completion of a criminal background, credit, driving record, and
professional reference checks</B>. The Company reserves the right to withdraw this offer based upon the results of the background and/or professional reference checks. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As an employee of the Company, you will have access to certain confidential information of the Company and you
may, during the course of your employment, develop certain information or inventions which will be the property of the Company. To protect the interests of the Company, you will need to sign the Company&#146;s Confidential Information, Invention
Assignment and Arbitration Agreement, as a condition of your employment. We wish to impress upon you that we do not want you, and we hereby direct you not to bring with you any confidential or proprietary material of any former employer or to
violate any other obligations you may have with any former employer. During the period that you render services to the Company, you agree to not engage in any employment, business or activity that is in any way competitive with the business or
proposed business of the Company. You will disclose to the Company in writing any other gainful employment, business or activity that you are currently associated with or participate in that competes with the Company. You will not assist any other
person or organization in competing with the Company or in preparing to engage in competition with the business or proposed business of the Company. You represent that your signing of this offer letter, agreement(s) beforementioned, if any, under
the Plan and your commencement of employment with the Company will not violate any agreement currently in place between yourself and current or past employers. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15821 Ventura Boulevard,
Suite 145 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Encino, California 91436 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">V40012019 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g287617dsp06.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">While we look forward to a long and profitable relationship, should you decide to accept our offer, you will be
an <FONT STYLE="white-space:nowrap">at-will</FONT> employee of the Company, which means the employment relationship can be terminated by either of us for any reason, at any time, with or without notice. No promises, assurances, or other conduct,
whether written or oral, can modify this paragraph unless set forth in a written agreement signed by you and the CEO of Zevia. Further, your participation in any stock option or benefit program is not to be regarded as assuring you of continuing
employment for any particular period of time.&nbsp;&nbsp;&nbsp;&nbsp; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Please note that because of employer regulations adopted in the Immigration Reform and Control Act of 1986,
within three (3)&nbsp;business days of starting your new position you will need to present documentation demonstrating that you have authorization to work in the United States. If you have questions about this requirement, which applies to U.S.
citizens and <FONT STYLE="white-space:nowrap">non-U.S.</FONT> citizens alike, you may contact our office and speak with our SVP, People. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This offer will remain open until <B>March</B><B></B><B>&nbsp;11, 2022 at 1700 hours PST. </B>If you decide to
accept our offer, and I hope you will, please sign this letter in the space indicated. Your signature will acknowledge that you have read and understood and agreed to the terms and conditions of this offer letter and the attached documents. Should
you have anything else that you wish to discuss, please do not hesitate to call me. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">11.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As a Zevia employee, you are required to follow its rules and regulations. Therefore, you will be asked to
acknowledge in writing that you have read the Zevia employee handbook, accessible through Zevia&#146;s HR department and public network. In order to retain necessary flexibility in the administration of its policies and procedures, Zevia reserves
the right to change or revise its policies, procedures, and benefits at any time. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">12.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">You and the Company agree to submit to mandatory and exclusive binding arbitration any controversy or claim
arising out of, or relating to, this Agreement or any breach hereof or your employment relationship, <I>provided, however</I>, that the parties retain their right to, and shall not be prohibited, limited or in any other way restricted from, seeking
or obtaining equitable relief from a court having jurisdiction over the parties. Such arbitration shall take place in Los Angeles County, California, as set forth in the Confidential Information, Invention Assignment and Arbitration Agreement, or to
be entered, into by and between you and the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">13.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This offer letter, the background check authorizations, the agreements referred to above constitute the entire
agreement between you and the Company regarding the terms and conditions of your employment, and they supersede all prior negotiations, representations or agreements between you and the Company. The provisions of this offer letter regarding &#147;at
will&#148; employment and arbitration may only be modified by a document signed by you and the CEO of the Company. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15821 Ventura Boulevard,
Suite 145 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Encino, California 91436 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">V40012019 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g287617dsp06.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We look forward to working with you at the Company. We are very excited about you joining our team, and we
look forward to a beneficial and fruitful relationship. Please sign and date this letter on the spaces provided below to acknowledge your acceptance of the terms of this offer letter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Very truly yours, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Paddy Spence</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Paddy Spence</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>CEO</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I have read and understood this offer letter and hereby acknowledge, accept and agree to the terms set forth above and further
acknowledge that no other commitments were made to me as part of my employment offer except as specifically set forth herein. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="42%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="42%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>DENISE&nbsp;D.&nbsp;BECKLES</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ DENISE&nbsp;D.&nbsp;BECKLES</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Date&nbsp;signed:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">3/11/2022</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Enclosures:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Confidential and Arbitration Agreements</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15821 Ventura Boulevard,
Suite 145 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Encino, California 91436 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">V40012019 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>d287617dex102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SEVERANCE AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This
<B>SEVERANCE AGREEMENT</B> (this &#147;<U>Agreement</U>&#148;) is entered into as of <B>May</B><B></B><B>&nbsp;1, 2022</B> (the &#147;<U>Effective Date</U>&#148;), by and between Zevia PBC, a Delaware public benefit corporation (the
&#147;<U>Company</U>&#148;), and <B>Denise D. Beckles</B> (&#147;<U>Executive</U>&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. <U><FONT STYLE="white-space:nowrap">At-Will</FONT>
Employment</U>. Executive acknowledges and agrees that Executive&#146;s employment relationship with the Company is at will. This Agreement does not in any way alter Executive&#146;s <FONT STYLE="white-space:nowrap">at-will</FONT> status or limit
the Company&#146;s or Executive&#146;s right to terminate Executive&#146;s employment with the Company at any time, with or without Cause or advance notice. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. <U>Definitions</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)
&#147;<U>Affiliate</U>&#148; means (i)&nbsp;all persons or entities directly or indirectly controlling, controlled by or under common control with the Company, (ii)&nbsp;all entities in which the Company directly or indirectly owns an equity
interest; and (iii)&nbsp;all predecessors, successors and assigns of those Affiliates identified in (i)&nbsp;and (ii). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)
&#147;<U>Arbitration Agreement</U>&#148; means that certain Mutual Arbitration Agreement between Executive and the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)
&#147;<U>Board</U>&#148; means the Board of Directors of the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) &#147;<U>Cause</U>&#148; means (i)&nbsp;Executive&#146;s failure
to materially perform Executive&#146;s duties and responsibilities to the Company and the Affiliates (other than any such failure resulting from incapacity due to physical or mental illness), other than any failure which is capable of cure and is
cured by Executive within 15 days following Executive&#146;s receipt of notice from the Company; (ii)&nbsp;Executive&#146;s failure to comply with any valid and legal directive of the Chief Executive Officer of the Company, Executive&#146;s
supervisor or the Board; (iii)&nbsp;Executive&#146;s engagement in conduct, which is, or could reasonably be expected to be, materially injurious to the Company or the Affiliates; (iv) Executive&#146;s embezzlement, misappropriation or fraud,
whether or not related to Executive&#146;s employment with the Company; (v)&nbsp;Executive&#146;s conviction of or plea of guilty or nolo contendere to a felony (or state law equivalent); or (vi)&nbsp;Executive&#146;s material breach of this
Agreement, the Confidentiality Agreement, or any other written agreement between the Company and Executive or any of the Company&#146;s material policies, including its code of conduct. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) &#147;<U>Change in Control</U>&#148; has the meaning set forth in the Zevia PBC 2021 Equity Incentive Plan or any successor equity
incentive plan. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) &#147;<U>CIC Protection Period</U>&#148; means the <FONT STYLE="white-space:nowrap">18-month</FONT> period beginning
on the consummation of a Change in Control. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) &#147;<U>Confidentiality Agreement</U>&#148; means that certain Employment, Confidential
Information, and Invention Assignment Agreement between Executive and the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) &#147;<U>Disability</U>&#148; means Executive is
unable to perform each of the essential duties of Executive&#146;s position by reason of a medically determinable physical or mental impairment which </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
is potentially permanent in character or which can be expected to last for a continuous period of not less than 12 months. A determination of Disability shall be made by the Board on the basis of
such medical evidence as the Board deems warranted under the circumstances, and in this respect, Executive shall submit to an examination by a physician upon request by the Board. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) &#147;<U>Good Reason</U>&#148; means the occurrence of any one or more of the following: (i)&nbsp;a material diminution in Executive&#146;s
annual base salary or target annual bonus; (ii)&nbsp;a material diminution in Executive&#146;s authority, duties or responsibilities with the Company or an Affiliate; or (iii)&nbsp;a required relocation of Executive&#146;s principal place of
employment by more than 50 miles; provided, however, that any assertation by Executive of Good Reason shall not be effective unless (A)&nbsp;Executive provides written notice to the Company of the existence of one or more of the foregoing conditions
within 30 days after the initial occurrence of such conditions; (B)&nbsp;the condition(s) specified in such notice must remain uncorrected for 30 days following the </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Company&#146;s receipt of such notice; and (C)&nbsp;the date of the termination of Executive&#146;s employment must occur within 90 days after
the initial occurrence of the condition(s) specified in such notice. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) &#147;<U>Qualifying Termination</U>&#148; means a termination of
Executive&#146;s employment with the Company by the Company without Cause (other than by reason of death or Disability) or by Executive for Good Reason. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) &#147;<U>Termination Date</U>&#148; means the date of Executive&#146;s termination of employment with the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. <U>Effect of Termination</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Accrued
Obligations</U>. Upon any termination of Executive&#146;s employment with the Company, Executive shall be entitled to receive: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)
Executive&#146;s base salary accrued through the Termination Date, payable as soon as practicable following the date of such termination or as otherwise required by applicable law; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Executive&#146;s accrued but unused vacation as of the Termination Date, payable as soon as practicable following the date of such
termination or as otherwise required by applicable law or Company policy; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) employee benefits, if any, as to which Executive may be
entitled under the employee benefit plans of the Company, which shall be paid in accordance with the terms of the applicable plans (the amounts described in clauses (A)&nbsp;through (C) hereof, the &#147;<U>Accrued Obligations</U>&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Qualifying Termination</U>. Upon a Qualifying Termination that does not occur during a CIC Protection Period, subject to
Executive&#146;s execution and <FONT STYLE="white-space:nowrap">non-revocation</FONT> of a release of claims, in the form provided by the Company (the &#147;<U>Release</U>&#148;), within the time period specified therein and Executive&#146;s
continued compliance with the provisions of the Confidentiality Agreement and <U>Sections 4</U>, <U>5</U>, <U>6</U> and <U>8(k)</U> Executive shall be entitled to receive: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) aggregate severance payments in an amount equal to the Executive&#146;s annual base
salary at the rate in effect on the Termination Date (and prior to any reduction that constitutes Good Reason), payable in equal installments in accordance with the Company&#146;s normal payroll practices for the 12 months following the date the
Release becomes effective and irrevocable; provided, that if the period during which the Release could become effective and irrevocable spans two calendar years, payments of such installments shall not commence until the first normal payroll date in
the second calendar year; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) subject to Executive&#146;s timely election of continuation coverage under the Consolidated Omnibus Budget
Reconciliation Act of 1985 (&#147;<U>COBRA</U>&#148;) and subject to Executive&#146;s copayment of premium amounts at the active employees&#146; rate, reimbursement for the amount of the remainder of the premiums for Executive&#146;s and his or her
covered dependents&#146; participation in the Company&#146;s group health plans pursuant to COBRA for a period ending on the earliest of (A)&nbsp;the first anniversary of the Termination Date, (B)&nbsp;Executive becoming eligible for other
employer-sponsored group health benefits or Medicare, and (C)&nbsp;the expiration of Executive&#146;s rights under COBRA; provided, however, that in the event that the benefits provided herein would subject the Company or any of the Affiliates to
any tax or penalty under the Patient Protection and Affordable Care Act (the &#147;<U>PPACA</U>&#148;) or Section&nbsp;105(h) of the Internal Revenue Code of 1986 (the &#147;<U>Code</U>&#148;), Executive and the Company agree to work together in
good faith to restructure the foregoing benefit; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) any earned but unpaid annual bonus for the fiscal year preceding the fiscal
year in which the Termination Date occurs, payable on the date when bonuses for such fiscal year are otherwise paid to the Company&#146;s executives for such fiscal year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Following Executive&#146;s Qualifying Termination that does not occur during a CIC Protection Period, except as set forth in this <U>Section&nbsp;3(b)</U>,
Executive shall have no further rights to any compensation or any other benefits under this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Qualifying Termination
during CIC Protection Period</U>. Upon a Qualifying Termination that occurs during a CIC Protection Period, subject to Executive&#146;s execution and <FONT STYLE="white-space:nowrap">non-revocation</FONT> of a Release within the time period
specified therein and Executive&#146;s continued compliance with the provisions of the Confidentiality Agreement and <U>Sections 4</U>, <U>5</U>, <U>6</U> and <U>8(k)</U> Executive shall be entitled to receive: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) a lump sum severance payment in an amount equal to the sum of (A)&nbsp;Executive&#146;s annual base salary at the rate in effect on the
Termination Date (and prior to any reduction that constitutes Good Reason) and (B)&nbsp;Executive&#146;s target annual bonus for the year in which the Termination Date occurs, payable within 60 days following the date the Release becomes effective
and irrevocable; provided, that if the period during which the Release could become effective and irrevocable spans two calendar years, payment shall occur in the second calendar year; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) subject to Executive&#146;s timely election of continuation coverage under COBRA, and subject to Executive&#146;s copayment of premium
amounts at the active employees&#146; rate, reimbursement for the amount of the remainder of the premiums for Executive&#146;s and his or her covered dependents&#146; participation in the Company&#146;s group health plans pursuant to COBRA for a
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
period ending on the earliest of (A)&nbsp;the first anniversary of the Termination Date, (B)&nbsp;Executive becoming eligible for other employer-sponsored group health benefits or Medicare, and
(C)&nbsp;the expiration of Executive&#146;s rights under COBRA; provided, however, that in the event that the benefits provided herein would subject the Company or any Affiliate to any tax or penalty under the PPACA or Section&nbsp;105(h) of the
Code, Executive and the Company agree to work together in good faith to restructure the foregoing benefit; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) any earned but unpaid
annual bonus for the fiscal year preceding the fiscal year in which the Termination Date occurs, payable on the date when bonuses for such fiscal year are otherwise paid to the Company&#146;s executives for such fiscal year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Following Executive&#146;s Qualifying Termination that occurs during a CIC Protection Period, except as set forth in this <U>Section&nbsp;3(c)</U>, Executive
shall have no further rights to any compensation or any other benefits under this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Other Terminations</U>. Upon a
termination of Executive&#146;s employment that is not described in <U>Section&nbsp;3(b)</U> or <U>Section&nbsp;3(c)</U>, except for the Accrued Obligations, Executive shall have no further rights to any compensation or any other benefits under this
Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)<U> Termination and Offices Held</U>. Upon termination of Executive&#146;s employment for any reason, Executive shall be
deemed to have resigned from all positions that Executive may then hold as an employee, officer or director of the Company or any Affiliate. Executive shall promptly deliver to the Company any additional documents reasonably required by the Company
to confirm such resignations. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. <U>Confidential Information</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) During the course of Executive&#146;s employment with the Company, Executive will be given access to and receive Company Confidential
Information (as defined in the Confidentiality Agreement) regarding the business of the Company and the Affiliates. Executive agrees that the Company Confidential Information constitutes a protectable business interest of the Company and the
Affiliates and covenants and agrees that at all times during Executive&#146;s employment with the Company, and at all times following Executive&#146;s termination for any reason, Executive will not, directly or indirectly, disclose any Company
Confidential Information other than in the proper performance of Executive&#146;s duties. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding the foregoing, nothing in
this Agreement shall prohibit or restrict Executive from lawfully: (i)&nbsp;initiating communications directly with, cooperating with, providing information to, causing information to be provided to, or otherwise assisting in an investigation by,
any governmental authority regarding a possible violation of any law; (ii)&nbsp;responding to any inquiry or legal process directed to Executive from any such governmental authority; (iii)&nbsp;testifying, participating or otherwise assisting in any
action or proceeding by any such governmental authority relating to a possible violation of law; or (iv)&nbsp;making any other disclosures that are protected under the whistleblower provisions of any applicable law. Additionally, pursuant to the
federal Defend Trade Secrets Act of 2016, an individual shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that: (A)&nbsp;is made (1)&nbsp;in confidence to a federal, state
or local government official, either directly or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
indirectly, or to an attorney and (2)&nbsp;solely for the purpose of reporting or investigating a suspected violation of law; (B)&nbsp;is made to the individual&#146;s attorney in relation to a
lawsuit for retaliation against the individual for reporting a suspected violation of law; or (C)&nbsp;is made in a complaint or other document filed in a lawsuit or proceeding, if such filing is made under seal. Nothing in this Agreement requires
Executive to obtain prior authorization before engaging in any conduct described in this paragraph, or to notify the Company that Executive has engaged in any such conduct. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. <U><FONT STYLE="white-space:nowrap">Non-Disparagement</FONT></U>. Executive shall not, while employed by the Company or at any time thereafter, disparage
the Company (or any Affiliate) in any way that materially and adversely affects the goodwill, reputation or business relationships of the Company or the Affiliate with the public generally, or with any of its customers, vendors or employees.
Executive shall not make comments to the media, including through social media, or otherwise regarding Executive&#146;s employment with the Company or the circumstances regarding the termination thereof without the prior written consent of the
Board. Notwithstanding the foregoing, this <U>Section&nbsp;5</U> shall not prohibit Executive from rebutting claims or statements made by any other person. Nothing in this Agreement prevents Executive from discussing or disclosing information about
unlawful acts in the workplace, such as harassment or discrimination or any other conduct that Executive has reason to believe is unlawful. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6. <U><FONT
STYLE="white-space:nowrap">Non-Competition;</FONT> <FONT STYLE="white-space:nowrap">Non-Solicitation</FONT></U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Executive
acknowledges that the Company has spent significant time, effort and resources protecting its Company Confidential Information and customer goodwill. Executive further acknowledges that the Company Confidential Information is of significant
competitive value to the Company in the supermarket and grocery industry in which it competes, and that the use or disclosure, even if inadvertent, of such Company Confidential Information for the benefit of a competitor would cause significant
damage to the legitimate business interests of the Company. Accordingly, in order to protect the legitimate business and customer goodwill interests of the Company, to protect that Company Confidential Information against inappropriate use or
disclosure, and in consideration for Executive&#146;s employment and the benefits provided to Executive herein, Executive agrees that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)
During the Restricted Period (as defined below) the Executive shall not, directly or indirectly (including as an employee, officer, director, owner, consultant, manager, or independent contractor), other than in connection with his employment by the
Company, engage in the Business (as defined below) in any country in which the Company or an Affiliate is engaged in the Business at the time of Executive&#146;s separation as an employee of the Company. The Restricted Period shall be extended for a
period equal to any time period that the Executive is in violation of this <U>Section&nbsp;6(a)(i)</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Without the prior written
consent of the Company, during the Restricted Period, Executive shall not, directly or indirectly, solicit, recruit or hire any person who is as of the date of his termination (or was within 12 months prior to the date of his termination) an
employee of the Company or an Affiliate; provided, however, that the foregoing provision shall not prohibit solicitations made by Executive to the general public, including through a general public posting site or forum. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) Without the prior written consent of the Company, during the Restricted Period,
Executive shall not directly or indirectly (A)&nbsp;solicit or encourage any client, customer, bona fide prospective client or customer, supplier, licensee, licensor, landlord or other business relation of the Company or any Affiliate with whom
Executive had material personal dealings in the <FONT STYLE="white-space:nowrap">12-month</FONT> period immediately preceding his termination (each a &#147;<U>Business Contact</U>&#148;) to terminate or diminish its relationship with them; or
(B)&nbsp;seek to persuade any such Business Contact to conduct with anyone else any business or activity conducted or, to Executive&#146;s knowledge, under consideration by the Company or any Affiliate as of the date of his termination that such
Business Contact conducts or could conduct with the Company or any Affiliate. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Nothing contained in this <U>Section&nbsp;6</U> shall be
construed to prevent Executive from (i)&nbsp;investing in the equity of any competing entity listed on a national securities exchange or traded in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT>
market, but only if Executive is not involved directly or indirectly in the management of said entity and if the Executive and the Executive&#146;s associates (as such term is defined in Regulation 14(A) promulgated under the Securities Exchange Act
of 1934, as in effect on the date hereof), collectively, do not own more than an aggregate of 5% of the equity of such entity, or (ii)&nbsp;indirectly owning securities through ownership of shares of a registered investment company or mutual fund.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) If a court of competent jurisdiction determines that any portion of this <U>Section&nbsp;6</U> is invalid or unenforceable, the
remainder of this <U>Section&nbsp;6</U> shall be given full effect without regard to the invalid provision. If any court of final and <FONT STYLE="white-space:nowrap">non-appealable</FONT> judgment construes any of the provisions of this
<U>Section&nbsp;6</U>, or any part thereof, to be unreasonable because of the duration, geographic location, or scope of such provision, such provision shall be deemed to be amended to cover the maximum duration, geographic location, and scope not
so determined to be unreasonable. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(d) As used herein: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) &#147;<U>Business</U>&#148; means the sale of <FONT STYLE="white-space:nowrap">non-alcoholic</FONT> liquid refreshment beverages. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) &#147;<U>Restricted Period</U>&#148; means during Executive&#146;s employment with the Company and the
<FONT STYLE="white-space:nowrap">12-month</FONT> period following the Termination Date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7. <U>Breach</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Executive acknowledges and agrees that the Company&#146;s remedies at law for a breach or threatened breach of any of the provisions of
<U>Sections 4</U>, <U>5</U> and <U>6(a)(ii)</U> would be inadequate and the Company would suffer irreparable damages as a result of such breach or threatened breach. In recognition of this fact, Executive agrees that, in the event of such a breach
or threatened breach, in addition to any remedies at law, the Company, without posting any bond, shall be entitled to cease making any payments or providing any benefit otherwise required by this Agreement and obtain equitable relief in the form of
specific performance, temporary restraining order, temporary or permanent injunction or any other equitable remedy which may then be available. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If, during the Restricted Period, Executive breaches his or her obligations under <U>Sections 4</U>, <U>5</U> or <U>6</U>, the Company
shall have the right to cease payments under <U>Section&nbsp;3(b)</U> and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<U>3(c)</U>, and Executive shall promptly return to the Company any payments received pursuant to <U>Section&nbsp;3(b)</U> or <U>3(c)</U>. Executive acknowledges that <U>Sections 6(a)(i)</U> and
<U>6(a)(iii)</U> are not intended to and do not prohibit the conduct described therein, but this <U>Section&nbsp;7(b)</U> provides for the forfeiture of the right to receive the severance payments and benefits under <U>Sections 3(b)</U> and
<U>3(c)</U> should Executive choose to violate such Sections during the Restricted Period. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8. <U>Miscellaneous</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Arbitration</U>. For the avoidance of doubt, the arbitration provisions of the Arbitration Agreement shall apply to any dispute
concerning Executive&#146;s employment with the Company or arising under or in any way related to this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Governing Law;
Consent to Personal Jurisdiction</U>. THIS AGREEMENT WILL BE GOVERNED BY THE LAWS OF THE STATE OF CALIFORNIA WITHOUT REGARD FOR CONFLICTS OF LAWS PRINCIPLES. SUBJECT TO THE ARBITRATION PROVISION IN THE ARBITRATION AGREEMENT, EXECUTIVE HEREBY
EXPRESSLY CONSENTS TO THE PERSONAL JURISDICTION OF THE STATE AND FEDERAL COURTS LOCATED IN CALIFORNIA FOR ANY LAWSUIT FILED THERE AGAINST EXECUTIVE BY THE COMPANY CONCERNING EXECUTIVE&#146;S EMPLOYMENT OR THE TERMINATION OF EXECUTIVE&#146;S
EMPLOYMENT OR ARISING FROM OR RELATING TO THIS AGREEMENT. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Entire Agreement/Amendments</U>. This Agreement, the Confidentiality
Agreement and the Arbitration Agreement contain the entire understanding of the parties with respect to the matters set forth herein; provided, however, that the covenants set forth in <U>Sections 4</U>, <U>5</U> and <U>6</U> shall be in addition
to, and not in lieu of, any other confidentiality, <FONT STYLE="white-space:nowrap">non-disparagement,</FONT> <FONT STYLE="white-space:nowrap">non-solicitation</FONT> or <FONT STYLE="white-space:nowrap">non-competition</FONT> covenants between
Executive and the Company or any Affiliate, including under the Confidentiality Agreement. There are no restrictions, agreements, promises, warranties, covenants or undertakings between the parties with respect to the subject matter herein other
than those expressly set forth herein or as may be set forth from time to time in the Company&#146;s employee benefit plans and policies applicable to Executive. For the avoidance of doubt, this Agreement supersedes and replaces any severance
entitlements set forth in any other agreement between the Company and Executive, including any individual employment agreement or offer letter. This Agreement may not be altered, modified, or amended except by written instrument signed by the
parties hereto. In the event of any inconsistency between this Agreement and any other plan, program, practice or agreement of which Executive is a participant or a party, this Agreement shall control unless such other plan, program, practice or
agreement specifically refers to the provisions of this sentence. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>No Waiver</U>. The failure of a party to insist upon strict
adherence to any term of this Agreement on any occasion shall not be considered a waiver of such party&#146;s rights or deprive such party of the right thereafter to insist upon strict adherence to that term or any other term of this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>Severability</U>. In the event that any one or more of the provisions of this Agreement shall be or become invalid, illegal or
unenforceable in any respect, the validity, legality and enforceability of the remaining provisions of this Agreement shall not be affected thereby. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <U>Assignment</U>. This Agreement, and all of Executive&#146;s rights and duties
hereunder, shall not be assignable or delegable by Executive. Any purported assignment or delegation by Executive in violation of the foregoing shall be null and <I>void ab initio</I> and of no force and effect. This Agreement may be assigned by the
Company to a person or entity which is an Affiliate or a successor in interest to substantially all of the business operations of the Company. Upon such assignment, the rights and obligations of the Company hereunder shall become the rights and
obligations of such Affiliate or successor person or entity. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <U>Counterclaim; No Mitigation</U>. The Company&#146;s obligation to pay
Executive the amounts provided and to make the arrangements provided hereunder shall be subject to counterclaim and to seek recoupment of amounts owed by Executive to the Company or the Affiliates. Executive shall not be required to mitigate the
amount of any payment provided for pursuant to this Agreement by seeking other employment, and such payments shall not be reduced by any compensation or benefits received from any subsequent employer or other endeavor. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <U>Compliance with Code Section&nbsp;409A</U>. Notwithstanding anything herein to the contrary, (i)&nbsp;if on the Termination Date
Executive is a &#147;specified employee&#148; as defined in Section&nbsp;409A of the Code and the deferral of the commencement of any payments or benefits otherwise payable hereunder as a result of such termination of employment is necessary in
order to prevent any accelerated or additional tax under Section&nbsp;409A of the Code, then the Company will defer the commencement of the payment of any such payments or benefits hereunder (without any reduction in such payments or benefits
ultimately paid or provided to Executive) until the date that is six months following Executive&#146;s termination of employment with the Company or Executive&#146;s earlier death (or the earliest date as is permitted under Section&nbsp;409A of the
Code) and (ii)&nbsp;if any other payments of money or other benefits due to Executive hereunder could cause the application of an accelerated or additional tax under Section&nbsp;409A of the Code, such payments or other benefits shall be deferred if
deferral will make such payment or other benefits compliant under Section&nbsp;409A of the Code, or otherwise such payment or other benefits shall be restructured, to the extent possible, in a manner, determined by the Board, that does not cause
such an accelerated or additional tax. For purposes of Section&nbsp;409A of the Code, each payment made under this Agreement shall be designated as a &#147;separate payment&#148; within the meaning of the Section&nbsp;409A of the Code, and
references herein to Executive&#146;s &#147;termination of employment&#148; shall refer to Executive&#146;s separation from service with the Company within the meaning of Section&nbsp;409A. To the extent any reimbursements or <FONT
STYLE="white-space:nowrap">in-kind</FONT> benefits due to Executive under this Agreement constitute &#147;deferred compensation&#148; under Section&nbsp;409A of the Code, any such reimbursements or <FONT STYLE="white-space:nowrap">in-kind</FONT>
benefits shall be paid to Executive in a manner consistent with Treas. Reg. <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-3(i)(1)(iv).</FONT> The Company shall consult with Executive in good faith regarding the implementation of the
provisions of this <U>Section&nbsp;8(h)</U>; <U>provided</U> that neither the Company nor any of its employees or representatives shall have any liability to Executive with respect to thereto or any tax imposed under Section&nbsp;409A. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <U>Successors; Binding Agreement</U>. This Agreement shall inure to the benefit of and be binding upon personal or legal representatives,
executors, administrators, successors, heirs, distributees, devisees and legatees. In the event of Executive&#146;s death prior to receipt of all amounts payable to Executive (including any unpaid amounts due under <U>Section&nbsp;3</U>), such
amounts shall be paid to Executive&#146;s beneficiary designated in a Notice provided to and accepted by the Company or, in the absence of such designation, to Executive&#146;s estate. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) <U>Notice</U>. For the purpose of this Agreement, notices and all other communications
provided for in the Agreement shall be in writing and shall be deemed to have been duly given when delivered by hand or overnight courier or three postal delivery days after it has been mailed by United States registered mail, return receipt
requested, postage prepaid, addressed to the respective addresses set forth below in this Agreement, or to such other address as either party may have furnished to the other in writing in accordance herewith, except that Notice of change of address
shall be effective only upon receipt (each such communication, &#147;<U>Notice</U>&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">If to the Company, addressed to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Zevia PBC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attn: General
Counsel </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">15821 Ventura Blvd., Suite 145 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Encino, CA 91436 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">If to
Executive, to the address listed in the Company&#146;s payroll records from time to time. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) <U>Cooperation</U>. Executive shall provide
Executive&#146;s reasonable cooperation in connection with any investigation, action or proceeding (or any appeal from any action or proceeding) which relates to events occurring during Executive&#146;s employment hereunder, provided, that,
following termination of Executive&#146;s employment, the Company shall pay all reasonable expenses incurred by Executive in providing such cooperation. This provision shall survive any termination of this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) <U>Withholding Taxes</U>. The Company may withhold from any amounts payable under this Agreement such federal, state and local taxes as may
be required to be withheld pursuant to any applicable law or regulation. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) <U>Interpretation</U>. Titles and headings to Sections hereof
are for the purpose of reference only and shall in no way limit, define or otherwise affect the provisions hereof. Unless the context requires otherwise, all references to laws, regulations, contracts, agreements and instruments refer to such laws,
regulations, contracts, agreements and instruments as they may be amended from time to time, and references to particular provisions of laws or regulations include a reference to the corresponding provisions of any succeeding law or regulation. All
references to &#147;dollars&#148; or &#147;$&#148; in this Agreement refer to United States dollars. The word &#147;or&#148; is not exclusive. The words &#147;herein&#148;, &#147;hereof&#148;, &#147;hereunder&#148; and other compounds of the word
&#147;here&#148; shall refer to the entire Agreement, including all Exhibits attached hereto, and not to any particular provision hereof. Wherever the context so requires, the masculine gender includes the feminine or neuter, and the singular number
includes the plural and conversely. All references to &#147;including&#148; shall be construed as meaning &#147;including without limitation.&#148; Neither this Agreement nor any uncertainty or ambiguity herein shall be construed or resolved against
any party hereto, whether under any rule of construction or otherwise. On the contrary, this Agreement has been reviewed by each of the parties hereto and shall be construed and interpreted according to the ordinary meaning of the words used so as
to fairly accomplish the purposes and intentions of the parties hereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) <U>Counterparts</U>. This Agreement may be signed in counterparts, each of which shall
be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page Follows this
Page] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have duly executed this Severance Agreement as of the
Effective Date. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>ZEVIA PBC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Lorna R. Simms</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Lorna R. Simms</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Senior Vice President, General Counsel and Corporate Secretary</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>EXECUTIVE</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Denise D. Beckles</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Denise D. Beckles</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S<SMALL>EVERANCE</SMALL> A<SMALL>GREEMENT</SMALL> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>d287617dex103.htm
<DESCRIPTION>EX-10.3
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.3 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g287617dsp06.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">March&nbsp;18, 2022 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Quincy
Troupe </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Re: <B>Offer of Employment by Zevia PBC</B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear
Quincy, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I am very pleased to confirm our offer to you of employment with Zevia PBC (the &#147;<B><I>Company</I></B>&#148;). Your estimated start date
will be <B>June&nbsp;13, 2022</B> or such other day as is mutually agreed upon. This offer and your employment relationship will be subject to the terms and conditions in this letter. The Company reserves the right to modify job titles, reporting
structures, wages and benefits from time to time as it deems necessary and appropriate. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">You will report to the <B>President</B>. Your job title will be <B>Chief Operating Officer.</B>
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As a regular full-time employee, you will be paid on a semi-monthly basis at an annual rate of <B>$385,000</B>
less payroll deductions and all required withholdings. The position is classified as exempt from the overtime provisions of state and federal law, which means you will not be paid overtime compensation. Your position will be subject to job
performance reviews. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In addition to your base pay, you will be entitled to receive a<B> $100,000</B> cash <FONT
STYLE="white-space:nowrap">sign-on</FONT> bonus payable in two equal installments of <B>50%</B> on <B>within <FONT STYLE="white-space:nowrap">30-days</FONT></B> from hire date, and <B>50%</B> at <B><FONT STYLE="white-space:nowrap">6-months</FONT>
from hire date,</B> less payroll deductions and all required withholdings, in the payroll period following your completion of six months of continued employment with the Company. The bonus will be subject to applicable supplemental taxation at the
federal and/or state levels(s) and will be subject to repayment in full in the event that you voluntarily resign your employment or are terminated for Cause (as defined in the Severance Agreement) within your first 12 months of employment.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">You will also be eligible to earn discretionary merit-based compensation and the Company reserves the right to
modify its plan for such potential additional compensation as circumstances change. Subject to you continuing employment with the Company through the bonus earning date, you will be eligible to earn a bonus upon your achieving certain milestones
that will be determined by the Company&#146;s Board of Directors. Your current merit-based compensation has an annual target of <B>75% of your annual salary</B> (subject to a <FONT STYLE="white-space:nowrap">pro-rata</FONT> amount based on hired
date). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to the approval of the Company&#146;s Compensation Committee of the Board of Directors, you will be
eligible to receive an annual long-term incentive (LTI) program award valued at <B>$650,000</B> per year, consisting of 50% stock options and 50% time-vested restricted stock units (RSUs) under the Zevia PBC 2021 Equity Incentive Plan the
(&#147;<B><I>Plan</I></B>&#148;) with vesting to occur in <FONT STYLE="white-space:nowrap">one-fourth</FONT> installments on each of the first four anniversaries of the grant date as </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15821 Ventura Boulevard, Suite 145 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Encino, California 91436 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">V40012019
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g287617dsp06.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">long as you are continuously employed by the Company through each anniversary date. You acknowledge that the LTI program and award amount will be formally approved by the Company&#146;s Compensation Committee of the
Board of Directors on or before the end of the Company&#146;s first quarter of fiscal year 2022. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">We are pleased to share that your benefit details, vacation, sick/personal days, and Company paid holidays will
be reviewed during your onboarding process, as well as included in the Employee Handbook referenced in this offer letter. You will have the opportunity to review the plans in detail, along with having access to your benefit information via your
employee online portal. Benefits and perks are subject to change during open enrollment, and as deemed appropriate by the Company, at any time. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Because we are dealing with inventions and proprietary information, we must take care that our employees do not
have any unusual incidents in their past which might adversely affect our brand&#146;s reputation and our consumer&#146;s trust in us. <B>This offer is contingent upon the satisfactory completion of a criminal background, credit, driving record, and
professional reference checks</B>. The Company reserves the right to withdraw this offer based upon the results of the background and/or professional reference checks. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As an employee of the Company, you will have access to certain confidential information of the Company and you
may, during the course of your employment, develop certain information or inventions which will be the property of the Company. To protect the interests of the Company, you will need to sign the Company&#146;s Confidential Information, Invention
Assignment and Arbitration Agreement, as a condition of your employment. We wish to impress upon you that we do not want you, and we hereby direct you not to bring with you any confidential or proprietary material of any former employer or to
violate any other obligations you may have with any former employer. During the period that you render services to the Company, you agree to not engage in any employment, business or activity that is in any way competitive with the business or
proposed business of the Company. You will disclose to the Company in writing any other gainful employment, business or activity that you are currently associated with or participate in that competes with the Company. You will not assist any other
person or organization in competing with the Company or in preparing to engage in competition with the business or proposed business of the Company. You represent that your signing of this offer letter, agreement(s) beforementioned, if any, under
the Plan and your commencement of employment with the Company will not violate any agreement currently in place between yourself and current or past employers. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">While we look forward to a long and profitable relationship, should you decide to accept our offer, you will be
an <FONT STYLE="white-space:nowrap">at-will</FONT> employee of the Company, which means the employment relationship can be terminated by either of us for any reason, at any time, with or without notice. No promises, assurances, or other conduct,
whether written or oral, can modify this paragraph unless set forth in a written agreement signed by you and the CEO of Zevia. Further, your participation in any stock option or benefit program is not to be regarded as assuring you of continuing
employment for any particular period of time. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15821 Ventura Boulevard,
Suite 145 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Encino, California 91436 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">V40012019 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g287617dsp06.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Please note that because of employer regulations adopted in the Immigration Reform and Control Act of 1986,
within three (3)&nbsp;business days of starting your new position you will need to present documentation demonstrating that you have authorization to work in the United States. If you have questions about this requirement, which applies to U.S.
citizens and <FONT STYLE="white-space:nowrap">non-U.S.</FONT> citizens alike, you may contact our office and speak with our SVP, People. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This offer will remain open until <B>March</B><B></B><B>&nbsp;25, 2022 at 1700 hours PST. </B>If you decide to
accept our offer, and I hope you will, please sign this letter in the space indicated. Your signature will acknowledge that you have read and understood and agreed to the terms and conditions of this offer letter and the attached documents. Should
you have anything else that you wish to discuss, please do not hesitate to call me. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">11.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As a Zevia employee, you are required to follow its rules and regulations. Therefore, you will be asked to
acknowledge in writing that you have read the Zevia employee handbook, accessible through Zevia&#146;s HR department and public network. In order to retain necessary flexibility in the administration of its policies and procedures, Zevia reserves
the right to change or revise its policies, procedures, and benefits at any time. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">12.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">You and the Company agree to submit to mandatory and exclusive binding arbitration any controversy or claim
arising out of, or relating to, this Agreement or any breach hereof or your employment relationship, <I>provided, however</I>, that the parties retain their right to, and shall not be prohibited, limited or in any other way restricted from, seeking
or obtaining equitable relief from a court having jurisdiction over the parties. Such arbitration shall take place in Los Angeles County, California, as set forth in the Confidential Information, Invention Assignment and Arbitration Agreement, or to
be entered, into by and between you and the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">13.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This offer letter, the background check authorizations, the agreements referred to above constitute the entire
agreement between you and the Company regarding the terms and conditions of your employment, and they supersede all prior negotiations, representations or agreements between you and the Company. The provisions of this offer letter regarding &#147;at
will&#148; employment and arbitration may only be modified by a document signed by you and the CEO of the Company. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We look forward to
working with you at the Company. We are very excited about you joining our team, and we look forward to a beneficial and fruitful relationship. Please sign and date this letter on the spaces provided below to acknowledge your acceptance of the terms
of this offer letter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Very truly yours, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15821 Ventura Boulevard,
Suite 145 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Encino, California 91436 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">V40012019 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g287617dsp06.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Amy Taylor</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Amy Taylor</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>President</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I have read and understood this offer letter and hereby acknowledge, accept and agree to the terms set forth above and further
acknowledge that no other commitments were made to me as part of my employment offer except as specifically set forth herein. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="42%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="42%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>QUINCY TROUPE</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ QUINCY TROUPE</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Date&nbsp;signed:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">3/22/2022</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Enclosures:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Confidential and Arbitration Agreements</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15821 Ventura Boulevard,
Suite 145 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Encino, California 91436 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">V40012019 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>d287617dex104.htm
<DESCRIPTION>EX-10.4
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.4</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.4 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SEVERANCE AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This
<B>SEVERANCE AGREEMENT</B> (this &#147;<U>Agreement</U>&#148;) is entered into as of <B>June&nbsp;13, 2022</B> (the &#147;<U>Effective Date</U>&#148;), by and between Zevia PBC, a Delaware public benefit corporation (the &#147;<U>Company</U>&#148;),
and <B>Quincy Troupe</B> (&#147;<U>Executive</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. <U><FONT STYLE="white-space:nowrap">At-Will</FONT> Employment</U>. Executive acknowledges and
agrees that Executive&#146;s employment relationship with the Company is at will. This Agreement does not in any way alter Executive&#146;s <FONT STYLE="white-space:nowrap">at-will</FONT> status or limit the Company&#146;s or Executive&#146;s right
to terminate Executive&#146;s employment with the Company at any time, with or without Cause or advance notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. <U>Definitions</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) &#147;<U>Affiliate</U>&#148; means (i)&nbsp;all persons or entities directly or indirectly controlling, controlled by or under common
control with the Company, (ii)&nbsp;all entities in which the Company directly or indirectly owns an equity interest; and (iii)&nbsp;all predecessors, successors and assigns of those Affiliates identified in (i)&nbsp;and (ii). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) &#147;<U>Arbitration Agreement</U>&#148; means that certain Mutual Arbitration Agreement between Executive and the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) &#147;<U>Board</U>&#148; means the Board of Directors of the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) &#147;<U>Cause</U>&#148; means (i)&nbsp;Executive&#146;s failure to materially perform Executive&#146;s duties and responsibilities to the
Company and the Affiliates (other than any such failure resulting from incapacity due to physical or mental illness), other than any failure which is capable of cure and is cured by Executive within 15 days following Executive&#146;s receipt of
notice from the Company; (ii)&nbsp;Executive&#146;s failure to comply with any valid and legal directive of the Chief Executive Officer of the Company, Executive&#146;s supervisor or the Board; (iii)&nbsp;Executive&#146;s engagement in conduct,
which is, or could reasonably be expected to be, materially injurious to the Company or the Affiliates; (iv) Executive&#146;s embezzlement, misappropriation or fraud, whether or not related to Executive&#146;s employment with the Company;
(v)&nbsp;Executive&#146;s conviction of or plea of guilty or nolo contendere to a felony (or state law equivalent); or (vi)&nbsp;Executive&#146;s material breach of this Agreement, the Confidentiality Agreement, or any other written agreement
between the Company and Executive or any of the Company&#146;s material policies, including its code of conduct. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) &#147;<U>Change in
Control</U>&#148; has the meaning set forth in the Zevia PBC 2021 Equity Incentive Plan or any successor equity incentive plan. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)
&#147;<U>CIC Protection Period</U>&#148; means the <FONT STYLE="white-space:nowrap">18-month</FONT> period beginning on the consummation of a Change in Control. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) &#147;<U>Confidentiality Agreement</U>&#148; means that certain Employment, Confidential Information, and Invention Assignment Agreement
between Executive and the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) &#147;<U>Disability</U>&#148; means Executive is unable to perform each of the essential duties of
Executive&#146;s position by reason of a medically determinable physical or mental impairment which </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">is potentially permanent in character or which can be expected to last for a continuous period of not less
than 12 months. A determination of Disability shall be made by the Board on the basis of such medical evidence as the Board deems warranted under the circumstances, and in this respect, Executive shall submit to an examination by a physician upon
request by the Board. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) &#147;<U>Good Reason</U>&#148; means the occurrence of any one or more of the following: (i)&nbsp;a material
diminution in Executive&#146;s annual base salary or target annual bonus; (ii)&nbsp;a material diminution in Executive&#146;s authority, duties or responsibilities with the Company or an Affiliate; or (iii)&nbsp;a required relocation of
Executive&#146;s principal place of employment by more than 50 miles; provided, however, that any assertation by Executive of Good Reason shall not be effective unless (A)&nbsp;Executive provides written notice to the Company of the existence of one
or more of the foregoing conditions within 30 days after the initial occurrence of such conditions; (B)&nbsp;the condition(s) specified in such notice must remain uncorrected for 30 days following the Company&#146;s receipt of such notice; and
(C)&nbsp;the date of the termination of Executive&#146;s employment must occur within 90 days after the initial occurrence of the condition(s) specified in such notice. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) &#147;<U>Qualifying Termination</U>&#148; means a termination of Executive&#146;s employment with the Company by the Company without Cause
(other than by reason of death or Disability) or by Executive for Good Reason. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) &#147;<U>Termination Date</U>&#148; means the date of
Executive&#146;s termination of employment with the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. <U>Effect of Termination</U>.&nbsp;&nbsp;&nbsp;&nbsp; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Accrued Obligations</U>. Upon any termination of Executive&#146;s employment with the Company, Executive shall be entitled to receive:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Executive&#146;s base salary accrued through the Termination Date, payable as soon as practicable following the date of such
termination or as otherwise required by applicable law; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Executive&#146;s accrued but unused vacation as of the Termination Date,
payable as soon as practicable following the date of such termination or as otherwise required by applicable law or Company policy; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii)
employee benefits, if any, as to which Executive may be entitled under the employee benefit plans of the Company, which shall be paid in accordance with the terms of the applicable plans (the amounts described in clauses (A)&nbsp;through (C) hereof,
the &#147;<U>Accrued Obligations</U>&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Qualifying Termination</U>. Upon a Qualifying Termination that does not occur during a
CIC Protection Period, subject to Executive&#146;s execution and <FONT STYLE="white-space:nowrap">non-revocation</FONT> of a release of claims, in the form provided by the Company (the &#147;<U>Release</U>&#148;), within the time period specified
therein and Executive&#146;s continued compliance with the provisions of the Confidentiality Agreement and <U>Sections 4</U>, <U>5</U>, <U>6</U> and <U>8(k)</U> Executive shall be entitled to receive: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) aggregate severance payments in an amount equal to the Executive&#146;s annual base
salary at the rate in effect on the Termination Date (and prior to any reduction that constitutes Good Reason), payable in equal installments in accordance with the Company&#146;s normal payroll practices for the 12 months following the date the
Release becomes effective and irrevocable; provided, that if the period during which the Release could become effective and irrevocable spans two calendar years, payments of such installments shall not commence until the first normal payroll date in
the second calendar year; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) subject to Executive&#146;s timely election of continuation coverage under the Consolidated Omnibus Budget
Reconciliation Act of 1985 (&#147;<U>COBRA</U>&#148;) and subject to Executive&#146;s copayment of premium amounts at the active employees&#146; rate, reimbursement for the amount of the remainder of the premiums for Executive&#146;s and his or her
covered dependents&#146; participation in the Company&#146;s group health plans pursuant to COBRA for a period ending on the earliest of (A)&nbsp;the first anniversary of the Termination Date, (B)&nbsp;Executive becoming eligible for other
employer-sponsored group health benefits or Medicare, and (C)&nbsp;the expiration of Executive&#146;s rights under COBRA; provided, however, that in the event that the benefits provided herein would subject the Company or any of the Affiliates to
any tax or penalty under the Patient Protection and Affordable Care Act (the &#147;<U>PPACA</U>&#148;) or Section&nbsp;105(h) of the Internal Revenue Code of 1986 (the &#147;<U>Code</U>&#148;), Executive and the Company agree to work together in
good faith to restructure the foregoing benefit; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) any earned but unpaid annual bonus for the fiscal year preceding the fiscal
year in which the Termination Date occurs, payable on the date when bonuses for such fiscal year are otherwise paid to the Company&#146;s executives for such fiscal year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Following Executive&#146;s Qualifying Termination that does not occur during a CIC Protection Period, except as set forth in this <U>Section&nbsp;3(b)</U>,
Executive shall have no further rights to any compensation or any other benefits under this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Qualifying Termination
during CIC Protection Period</U>. Upon a Qualifying Termination that occurs during a CIC Protection Period, subject to Executive&#146;s execution and <FONT STYLE="white-space:nowrap">non-revocation</FONT> of a Release within the time period
specified therein and Executive&#146;s continued compliance with the provisions of the Confidentiality Agreement and <U>Sections 4</U>, <U>5</U>, <U>6</U> and <U>8(k)</U> Executive shall be entitled to receive: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) a lump sum severance payment in an amount equal to the sum of (A)&nbsp;Executive&#146;s annual base salary at the rate in effect on the
Termination Date (and prior to any reduction that constitutes Good Reason) and (B)&nbsp;Executive&#146;s target annual bonus for the year in which the Termination Date occurs, payable within 60 days following the date the Release becomes effective
and irrevocable; provided, that if the period during which the Release could become effective and irrevocable spans two calendar years, payment shall occur in the second calendar year; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) subject to Executive&#146;s timely election of continuation coverage under COBRA, and subject to Executive&#146;s copayment of premium
amounts at the active employees&#146; rate, reimbursement for the amount of the remainder of the premiums for Executive&#146;s and his or her covered dependents&#146; participation in the Company&#146;s group health plans pursuant to COBRA for a
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">period ending on the earliest of (A)&nbsp;the first anniversary of the Termination Date, (B)&nbsp;Executive
becoming eligible for other employer-sponsored group health benefits or Medicare, and (C)&nbsp;the expiration of Executive&#146;s rights under COBRA; provided, however, that in the event that the benefits provided herein would subject the Company or
any Affiliate to any tax or penalty under the PPACA or Section&nbsp;105(h) of the Code, Executive and the Company agree to work together in good faith to restructure the foregoing benefit; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) any earned but unpaid annual bonus for the fiscal year preceding the fiscal year in which the Termination Date occurs, payable on the
date when bonuses for such fiscal year are otherwise paid to the Company&#146;s executives for such fiscal year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Following Executive&#146;s Qualifying
Termination that occurs during a CIC Protection Period, except as set forth in this <U>Section&nbsp;3(c)</U>, Executive shall have no further rights to any compensation or any other benefits under this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Other Terminations</U>. Upon a termination of Executive&#146;s employment that is not described in <U>Section&nbsp;3(b)</U> or
<U>Section&nbsp;3(c)</U>, except for the Accrued Obligations, Executive shall have no further rights to any compensation or any other benefits under this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>Termination and Offices Held</U>. Upon termination of Executive&#146;s employment for any reason, Executive shall be deemed to have
resigned from all positions that Executive may then hold as an employee, officer or director of the Company or any Affiliate. Executive shall promptly deliver to the Company any additional documents reasonably required by the Company to confirm such
resignations. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. <U>Confidential Information</U>.&nbsp;&nbsp;&nbsp;&nbsp; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) During the course of Executive&#146;s employment with the Company, Executive will be given access to and receive Company Confidential
Information (as defined in the Confidentiality Agreement) regarding the business of the Company and the Affiliates. Executive agrees that the Company Confidential Information constitutes a protectable business interest of the Company and the
Affiliates and covenants and agrees that at all times during Executive&#146;s employment with the Company, and at all times following Executive&#146;s termination for any reason, Executive will not, directly or indirectly, disclose any Company
Confidential Information other than in the proper performance of Executive&#146;s duties. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding the foregoing, nothing in
this Agreement shall prohibit or restrict Executive from lawfully: (i)&nbsp;initiating communications directly with, cooperating with, providing information to, causing information to be provided to, or otherwise assisting in an investigation by,
any governmental authority regarding a possible violation of any law; (ii)&nbsp;responding to any inquiry or legal process directed to Executive from any such governmental authority; (iii)&nbsp;testifying, participating or otherwise assisting in any
action or proceeding by any such governmental authority relating to a possible violation of law; or (iv)&nbsp;making any other disclosures that are protected under the whistleblower provisions of any applicable law. Additionally, pursuant to the
federal Defend Trade Secrets Act of 2016, an individual shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that: (A)&nbsp;is made (1)&nbsp;in confidence to a federal, state
or local government official, either directly or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">indirectly, or to an attorney and (2)&nbsp;solely for the purpose of reporting or investigating a suspected
violation of law; (B)&nbsp;is made to the individual&#146;s attorney in relation to a lawsuit for retaliation against the individual for reporting a suspected violation of law; or (C)&nbsp;is made in a complaint or other document filed in a lawsuit
or proceeding, if such filing is made under seal. Nothing in this Agreement requires Executive to obtain prior authorization before engaging in any conduct described in this paragraph, or to notify the Company that Executive has engaged in any such
conduct. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. <U><FONT STYLE="white-space:nowrap">Non-Disparagement</FONT></U>. Executive shall not, while employed by the Company or at any time
thereafter, disparage the Company (or any Affiliate) in any way that materially and adversely affects the goodwill, reputation or business relationships of the Company or the Affiliate with the public generally, or with any of its customers, vendors
or employees. Executive shall not make comments to the media, including through social media, or otherwise regarding Executive&#146;s employment with the Company or the circumstances regarding the termination thereof without the prior written
consent of the Board. Notwithstanding the foregoing, this <U>Section&nbsp;5</U> shall not prohibit Executive from rebutting claims or statements made by any other person. Nothing in this Agreement prevents Executive from discussing or disclosing
information about unlawful acts in the workplace, such as harassment or discrimination or any other conduct that Executive has reason to believe is unlawful. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6. <U><FONT STYLE="white-space:nowrap">Non-Competition;</FONT> <FONT STYLE="white-space:nowrap">Non-Solicitation</FONT></U>.&nbsp;&nbsp;&nbsp;&nbsp; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Executive acknowledges that the Company has spent significant time, effort and resources protecting its Company Confidential Information
and customer goodwill. Executive further acknowledges that the Company Confidential Information is of significant competitive value to the Company in the supermarket and grocery industry in which it competes, and that the use or disclosure, even if
inadvertent, of such Company Confidential Information for the benefit of a competitor would cause significant damage to the legitimate business interests of the Company. Accordingly, in order to protect the legitimate business and customer goodwill
interests of the Company, to protect that Company Confidential Information against inappropriate use or disclosure, and in consideration for Executive&#146;s employment and the benefits provided to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive herein, Executive agrees that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)
During the Restricted Period (as defined below) the Executive shall not, directly or indirectly (including as an employee, officer, director, owner, consultant, manager, or independent contractor), other than in connection with his employment by the
Company, engage in the Business (as defined below) in any country in which the Company or an Affiliate is engaged in the Business at the time of Executive&#146;s separation as an employee of the Company. The Restricted Period shall be extended for a
period equal to any time period that the Executive is in violation of this <U>Section&nbsp;6(a)(i)</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Without the prior written
consent of the Company, during the Restricted Period, Executive shall not, directly or indirectly, solicit, recruit or hire any person who is as of the date of his termination (or was within 12 months prior to the date of his termination) an
employee of the Company or an Affiliate; provided, however, that the foregoing provision shall not prohibit solicitations made by Executive to the general public, including through a general public posting site or forum. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) Without the prior written consent of the Company, during the Restricted Period,
Executive shall not directly or indirectly (A)&nbsp;solicit or encourage any client, customer, bona fide prospective client or customer, supplier, licensee, licensor, landlord or other business relation of the Company or any Affiliate with whom
Executive had material personal dealings in the <FONT STYLE="white-space:nowrap">12-month</FONT> period immediately preceding his termination (each a &#147;<U>Business Contact</U>&#148;) to terminate or diminish its relationship with them; or
(B)&nbsp;seek to persuade any such Business Contact to conduct with anyone else any business or activity conducted or, to Executive&#146;s knowledge, under consideration by the Company or any Affiliate as of the date of his termination that such
Business Contact conducts or could conduct with the Company or any Affiliate. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Nothing contained in this <U>Section&nbsp;6</U> shall be
construed to prevent Executive from (i)&nbsp;investing in the equity of any competing entity listed on a national securities exchange or traded in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT>
market, but only if Executive is not involved directly or indirectly in the management of said entity and if the Executive and the Executive&#146;s associates (as such term is defined in Regulation 14(A) promulgated under the Securities Exchange Act
of 1934, as in effect on the date hereof), collectively, do not own more than an aggregate of 5% of the equity of such entity, or (ii)&nbsp;indirectly owning securities through ownership of shares of a registered investment company or mutual fund.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) If a court of competent jurisdiction determines that any portion of this <U>Section&nbsp;6</U> is invalid or unenforceable, the
remainder of this <U>Section&nbsp;6</U> shall be given full effect without regard to the invalid provision. If any court of final and <FONT STYLE="white-space:nowrap">non-appealable</FONT> judgment construes any of the provisions of this
<U>Section&nbsp;6</U>, or any part thereof, to be unreasonable because of the duration, geographic location, or scope of such provision, such provision shall be deemed to be amended to cover the maximum duration, geographic location, and scope not
so determined to be unreasonable. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) As used herein: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) &#147;<U>Business</U>&#148; means the sale of <FONT STYLE="white-space:nowrap">non-alcoholic</FONT> liquid refreshment beverages. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) &#147;<U>Restricted Period</U>&#148; means during Executive&#146;s employment with the Company and the
<FONT STYLE="white-space:nowrap">12-month</FONT> period following the Termination Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7. <U>Breach</U>.&nbsp;&nbsp;&nbsp;&nbsp; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Executive acknowledges and agrees that the Company&#146;s remedies at law for a breach or threatened breach of any of the provisions of
<U>Sections 4</U>, <U>5</U> and <U>6(a)(ii)</U> would be inadequate and the Company would suffer irreparable damages as a result of such breach or threatened breach. In recognition of this fact, Executive agrees that, in the event of such a breach
or threatened breach, in addition to any remedies at law, the Company, without posting any bond, shall be entitled to cease making any payments or providing any benefit otherwise required by this Agreement and obtain equitable relief in the form of
specific performance, temporary restraining order, temporary or permanent injunction or any other equitable remedy which may then be available. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If, during the Restricted Period, Executive breaches his or her obligations under <U>Sections 4</U>, <U>5</U> or <U>6</U>, the Company
shall have the right to cease payments under <U>Section&nbsp;3(b)</U> and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<U>3(c)</U>, and Executive shall promptly return to the Company any payments received pursuant to <U>Section&nbsp;3(b)</U> or <U>3(c)</U>. Executive acknowledges that <U>Sections 6(a)(i)</U> and
<U>6(a)(iii)</U> are not intended to and do not prohibit the conduct described therein, but this <U>Section&nbsp;7(b)</U> provides for the forfeiture of the right to receive the severance payments and benefits under <U>Sections 3(b)</U> and
<U>3(c)</U> should Executive choose to violate such Sections during the Restricted Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8. <U>Miscellaneous</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Arbitration</U>. For the avoidance of doubt, the arbitration provisions of the Arbitration Agreement shall apply to any dispute
concerning Executive&#146;s employment with the Company or arising under or in any way related to this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Governing
Law</U><U>; Consent to Personal Jurisdiction</U>. THIS AGREEMENT WILL BE GOVERNED BY THE LAWS OF THE STATE OF CALIFORNIA WITHOUT REGARD FOR CONFLICTS OF LAWS PRINCIPLES. SUBJECT TO THE ARBITRATION PROVISION IN THE ARBITRATION AGREEMENT, EXECUTIVE
HEREBY EXPRESSLY CONSENTS TO THE PERSONAL JURISDICTION OF THE STATE AND FEDERAL COURTS LOCATED IN CALIFORNIA FOR ANY LAWSUIT FILED THERE AGAINST EXECUTIVE BY THE COMPANY CONCERNING EXECUTIVE&#146;S EMPLOYMENT OR THE TERMINATION OF EXECUTIVE&#146;S
EMPLOYMENT OR ARISING FROM OR RELATING TO THIS AGREEMENT. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Entire Agreement/Amendments</U>. This Agreement, the Confidentiality
Agreement and the Arbitration Agreement contain the entire understanding of the parties with respect to the matters set forth herein; provided, however, that the covenants set forth in S<U>ections 4</U>, <U>5</U> and <U>6</U> shall be in addition
to, and not in lieu of, any other confidentiality, <FONT STYLE="white-space:nowrap">non-disparagement,</FONT> <FONT STYLE="white-space:nowrap">non-solicitation</FONT> or <FONT STYLE="white-space:nowrap">non-competition</FONT> covenants between
Executive and the Company or any Affiliate, including under the Confidentiality Agreement. There are no restrictions, agreements, promises, warranties, covenants or undertakings between the parties with respect to the subject matter herein other
than those expressly set forth herein or as may be set forth from time to time in the Company&#146;s employee benefit plans and policies applicable to Executive. For the avoidance of doubt, this Agreement supersedes and replaces any severance
entitlements set forth in any other agreement between the Company and Executive, including any individual employment agreement or offer letter. This Agreement may not be altered, modified, or amended except by written instrument signed by the
parties hereto. In the event of any inconsistency between this Agreement and any other plan, program, practice or agreement of which Executive is a participant or a party, this Agreement shall control unless such other plan, program, practice or
agreement specifically refers to the provisions of this sentence. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>No Waiver</U>. The failure of a party to insist upon strict
adherence to any term of this Agreement on any occasion shall not be considered a waiver of such party&#146;s rights or deprive such party of the right thereafter to insist upon strict adherence to that term or any other term of this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>Severability</U>. In the event that any one or more of the provisions of this Agreement shall be or become invalid, illegal or
unenforceable in any respect, the validity, legality and enforceability of the remaining provisions of this Agreement shall not be affected thereby. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <U>Assignment</U>. This Agreement, and all of Executive&#146;s rights and duties
hereunder, shall not be assignable or delegable by Executive. Any purported assignment or delegation by Executive in violation of the foregoing shall be null and <I>void ab initio</I> and of no force and effect. This Agreement may be assigned by the
Company to a person or entity which is an Affiliate or a successor in interest to substantially all of the business operations of the Company. Upon such assignment, the rights and obligations of the Company hereunder shall become the rights and
obligations of such Affiliate or successor person or entity. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <U>Counterclaim</U>; No Mitigation. The Company&#146;s obligation to pay
Executive the amounts provided and to make the arrangements provided hereunder shall be subject to counterclaim and to seek recoupment of amounts owed by Executive to the Company or the Affiliates. Executive shall not be required to mitigate the
amount of any payment provided for pursuant to this Agreement by seeking other employment, and such payments shall not be reduced by any compensation or benefits received from any subsequent employer or other endeavor. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <U>Compliance with Code Section&nbsp;409A</U>. Notwithstanding anything herein to the contrary, (i)&nbsp;if on the Termination Date
Executive is a &#147;specified employee&#148; as defined in Section&nbsp;409A of the Code and the deferral of the commencement of any payments or benefits otherwise payable hereunder as a result of such termination of employment is necessary in
order to prevent any accelerated or additional tax under Section&nbsp;409A of the Code, then the Company will defer the commencement of the payment of any such payments or benefits hereunder (without any reduction in such payments or benefits
ultimately paid or provided to Executive) until the date that is six months following Executive&#146;s termination of employment with the Company or Executive&#146;s earlier death (or the earliest date as is permitted under Section&nbsp;409A of the
Code) and (ii)&nbsp;if any other payments of money or other benefits due to Executive hereunder could cause the application of an accelerated or additional tax under Section&nbsp;409A of the Code, such payments or other benefits shall be deferred if
deferral will make such payment or other benefits compliant under Section&nbsp;409A of the Code, or otherwise such payment or other benefits shall be restructured, to the extent possible, in a manner, determined by the Board, that does not cause
such an accelerated or additional tax. For purposes of Section&nbsp;409A of the Code, each payment made under this Agreement shall be designated as a &#147;separate payment&#148; within the meaning of the Section&nbsp;409A of the Code, and
references herein to Executive&#146;s &#147;termination of employment&#148; shall refer to Executive&#146;s separation from service with the Company within the meaning of Section&nbsp;409A. To the extent any reimbursements or <FONT
STYLE="white-space:nowrap">in-kind</FONT> benefits due to Executive under this Agreement constitute &#147;deferred compensation&#148; under Section&nbsp;409A of the Code, any such reimbursements or <FONT STYLE="white-space:nowrap">in-kind</FONT>
benefits shall be paid to Executive in a manner consistent with Treas. Reg. <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-3(i)(1)(iv).</FONT> The Company shall consult with Executive in good faith regarding the implementation of the
provisions of this <U>Section&nbsp;8(h)</U>; <U>provided</U> that neither the Company nor any of its employees or representatives shall have any liability to Executive with respect to thereto or any tax imposed under Section&nbsp;409A. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <U>Successors; Binding Agreement</U>. This Agreement shall inure to the benefit of and be binding upon personal or legal representatives,
executors, administrators, successors, heirs, distributees, devisees and legatees. In the event of Executive&#146;s death prior to receipt of all amounts payable to Executive (including any unpaid amounts due under <U>Section&nbsp;3</U>), such
amounts shall be paid to Executive&#146;s beneficiary designated in a Notice provided to and accepted by the Company or, in the absence of such designation, to Executive&#146;s estate. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) <U>Notice</U>. For the purpose of this Agreement, notices and all other communications
provided for in the Agreement shall be in writing and shall be deemed to have been duly given when delivered by hand or overnight courier or three postal delivery days after it has been mailed by United States registered mail, return receipt
requested, postage prepaid, addressed to the respective addresses set forth below in this Agreement, or to such other address as either party may have furnished to the other in writing in accordance herewith, except that Notice of change of address
shall be effective only upon receipt (each such communication, &#147;<U>Notice</U>&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If to the Company, addressed to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Zevia PBC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attn: General
Counsel </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">15821 Ventura Blvd., Suite 145 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Encino, CA 91436 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If to
Executive, to the address listed in the Company&#146;s payroll records from time to time. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) <U>Cooperation</U>. Executive shall provide
Executive&#146;s reasonable cooperation in connection with any investigation, action or proceeding (or any appeal from any action or proceeding) which relates to events occurring during Executive&#146;s employment hereunder, provided, that,
following termination of Executive&#146;s employment, the Company shall pay all reasonable expenses incurred by Executive in providing such cooperation. This provision shall survive any termination of this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) <U>Withholding Taxes</U>. The Company may withhold from any amounts payable under this Agreement such federal, state and local taxes as may
be required to be withheld pursuant to any applicable law or regulation. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) <U>Interpretation</U>. Titles and headings to Sections hereof
are for the purpose of reference only and shall in no way limit, define or otherwise affect the provisions hereof. Unless the context requires otherwise, all references to laws, regulations, contracts, agreements and instruments refer to such laws,
regulations, contracts, agreements and instruments as they may be amended from time to time, and references to particular provisions of laws or regulations include a reference to the corresponding provisions of any succeeding law or regulation. All
references to &#147;dollars&#148; or &#147;$&#148; in this Agreement refer to United States dollars. The word &#147;or&#148; is not exclusive. The words &#147;herein&#148;, &#147;hereof&#148;, &#147;hereunder&#148; and other compounds of the word
&#147;here&#148; shall refer to the entire Agreement, including all Exhibits attached hereto, and not to any particular provision hereof. Wherever the context so requires, the masculine gender includes the feminine or neuter, and the singular number
includes the plural and conversely. All references to &#147;including&#148; shall be construed as meaning &#147;including without limitation.&#148; Neither this Agreement nor any uncertainty or ambiguity herein shall be construed or resolved against
any party hereto, whether under any rule of construction or otherwise. On the contrary, this Agreement has been reviewed by each of the parties hereto and shall be construed and interpreted according to the ordinary meaning of the words used so as
to fairly accomplish the purposes and intentions of the parties hereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) <U>Counterparts</U>. This Agreement may be signed in counterparts, each of which shall
be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page Follows this
Page] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have duly executed this Severance Agreement as of the
Effective Date. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>ZEVIA PBC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Lorna R. Simms</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Lorna R. Simms</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Senior Vice President, General Counsel and</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Corporate Secretary</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>EXECUTIVE</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Quincy Troupe</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: Quincy Troupe</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S<SMALL>EVERANCE</SMALL> A<SMALL>GREEMENT</SMALL> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>6
<FILENAME>d287617dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Zevia Announces Leadership Transitions with Appointments </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>of New Chief Financial Officer and Chief Operating Officer </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Denise Beckles Appointed Chief Financial Officer </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Quincy Troupe Appointed Chief Operating Officer </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>LOS ANGELES, Calif., April</B><B></B><B>&nbsp;25, 2022</B> &#150; Zevia PBC (&#147;Zevia&#148; or &#147;the Company&#148;) (NYSE: ZVIA), the company
disrupting the liquid refreshment beverage industry with great tasting, zero sugar beverages made with simple, plant-based ingredients, today announced the appointments of Denise Beckles as Chief Financial Officer and Quincy Troupe as Chief
Operating Officer, effective May&nbsp;3, 2022, and June&nbsp;13, 2022, respectively. Beckles brings over 25 years of finance leadership experience and will oversee the Company&#146;s Finance organization, playing a key role in executing Zevia&#146;s
strategy to drive profitable growth and enhance shareholder value. Troupe is a <FONT STYLE="white-space:nowrap">25-year</FONT> veteran of the consumer-packaged goods industry and has served on Zevia&#146;s Board of Directors since June 2021. Troupe
will transition from the Board to assume the role of Chief Operating Officer, in which he will lead product innovation and information technology, and drive supply chain optimization to support growth and profitability initiatives. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We are thrilled to welcome Denise and Quincy to Zevia&#146;s management team, as their respective skillsets comprise deep beverage and consumer industry
expertise across strategic, financial and operational functions,&#148; said Paddy Spence, Chair and Chief Executive Officer of Zevia. &#147;As we continue transforming the organization, their leadership will be critical to scaling our business,
driving growth, profitability and value creation.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;I am excited to join Zevia&#146;s impressive management team as the company continues to
execute its long-term growth plan. I look forward to helping the team deliver growth and accelerate profitability, while meeting increasing consumer demand for a product that tastes great with zero sugar. I am proud to contribute to a company where
improving people&#146;s lives and the environment is at the forefront of every business decision,&#148; said Beckles. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;It has been an immense
privilege to serve on Zevia&#146;s board over the last year, and I look forward to joining the management team. I am proud to be part of a company that not only has a clear vision for growth, but also is driven by a mission to support the health of
individuals and communities,&#148; said Troupe. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Current Chief Financial Officer, Bill Beech, will step down from his role as CFO effective May&nbsp;3,
2022, and from his employment, effective May&nbsp;6, 2022. Current Chief Operating Officer, Hank Margolis, will step down from his role as COO effective June&nbsp;13, 2022, and retire, effective June&nbsp;24, 2022. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;With these appointments, we look forward to continuing to advance our mission to support the health of individuals and the communities we serve with our
affordable, zero sugar beverages made with simple, plant-based ingredients,&#148; Spence concluded. &#147;On behalf of the Board, management team and everyone at Zevia, I want to thank Bill and Hank for their leadership and significant
contributions, especially during our transition to becoming a public company.&#148; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Denise Beckles </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ms.&nbsp;Beckles has over 25 years of progressive experience in finance, strategy, and operations with a strong focus on commercial and operational excellence.
Most recently, she served as Chief Financial Officer and Chief Operating Officer of Sol de Janeiro, one of the fastest-growing premium skincare brands in North America, where she was responsible for the Finance, IT, Legal, HR, Operations and Supply
Chain functions. Prior to that, Ms.&nbsp;Beckles served as the Chief Financial Officer for Revolution Foods, partnering with the Chief Executive Officer and Executive Team to drive strong double-digit growth and sustainable profitability.
Previously, she held three roles at Godiva Chocolatier, including Chief Financial Officer of North America, Chief Strategy Officer and Global Head of Financial Planning and Analysis. Ms.&nbsp;Beckles also spent over five years with Pernod Ricard USA
where she held various senior leadership roles in finance, strategy, and business development. She earned a B.S. in accounting and finance and an MBA from Clarkson University. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Quincy Troupe </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Troupe is a <FONT
STYLE="white-space:nowrap">25-year</FONT> veteran of the consumer-packaged goods, food and beverage industry, and has served in a variety of leadership roles in manufacturing, engineering, supply chain strategy and planning, human resources, and
enterprise shared services. Most recently, he served as Senior Vice President of Supply Chain at The Boston Beer Company, where he led a multi-year capacity and capability expansion program and operational improvements that enabled Boston Beer to
more than double in size and become one of the fastest growing beverage companies in the world. From 2010 to 2015, he served as Vice President of Supply Chain, and subsequently, Vice President of Manufacturing and Supply Chain Strategy, for the
Pepperidge Farm brand at Campbell Soup Company. Prior to Campbell Soup, Mr.&nbsp;Troupe served in various roles at Mars, Incorporated, including as Director of Mars Chocolate Innovation and Operating Systems. Mr.&nbsp;Troupe has served as a Director
on the Board for Zevia PBC since June 2021. He earned a B.S. in mechanical engineering from the State University of New York at Stony Brook. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>About
Zevia</U> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Zevia PBC, a public benefit corporation designated as a &#147;Certified B Corporation,&#148; is focused on addressing the global health
challenges resulting from excess sugar consumption by offering a broad portfolio of zero sugar, zero calorie, naturally sweetened beverages. All Zevia<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> beverages are made with a handful of
simple, plant-based ingredients, contain no artificial sweeteners, and are <FONT STYLE="white-space:nowrap">Non-GMO</FONT> Project verified, gluten-free, Kosher, vegan and zero sodium. As of 2021,
Zevia<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> beverages are distributed in more than 31,000 retail locations in the U.S. and Canada through a diverse network of major retailers in the food, drug, mass, natural and ecommerce
channels. For more information, please visit <U>www.zevia.com</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">(ZEVIA-F)</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Forward-Looking Statements </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release contains
&#147;forward-looking statements&#148; within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, any statement that may predict, forecast,
indicate or imply future results, performance or achievements, and may contain words such as &#147;believe,&#148; &#147;anticipate,&#148; &#147;expect,&#148; &#147;estimate,&#148; &#147;intend,&#148; &#147;project,&#148; &#147;plan,&#148; or words
or phrases with similar meaning. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be
achieved. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Forward-looking statements are based on current expectations, forecasts and assumptions that involve risks and uncertainties that may cause our business, strategy or actual results to differ
materially from the forward-looking statements. We do not intend and undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by applicable law.
Investors are referred to our filings with the SEC for additional information regarding the risks and uncertainties that may cause actual results to differ materially from those expressed in any forward-looking statement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Contacts </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Media </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Annie Samuelson </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Edelman </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">713-299-4115</FONT></FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Annie.Samuelson@edelman.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investors </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Reed Anderson </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ICR </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">646-277-1260</FONT></FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Reed.Anderson@icrinc.com </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>zvia-20220424.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20220115.12 -->
<!-- Creation date: 4/26/2022 2:01:29 AM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2021-01-31"
  xmlns:zvia="http://www.zevia.com/20220424"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.zevia.com/20220424"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" namespace="http://xbrl.sec.gov/dei/2021" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd" namespace="http://xbrl.sec.gov/naics/2021" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="zvia-20220424_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="zvia-20220424_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.zevia.com//20220424/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>zvia-20220424_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20220115.12 -->
<!-- Creation date: 4/26/2022 2:01:29 AM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>zvia-20220424_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20220115.12 -->
<!-- Creation date: 4/26/2022 2:01:29 AM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.zevia.com//20220424/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="zvia-20220424.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.zevia.com//20220424/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g287617dsp06.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g287617dsp06.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M)F?I/B=-9U4VUM$PB52[,ZX('Y^IK*EB/:SY8K0RI8GVL^6*T.AKJ.L* "@
MH * "@ H * "@ H * "@ H \COEFMO$UPL<IMY!.VU\XQSP<UX<TXU6EIJ>!
M-.-5I.VIVWAGQ(VH,;"^PE['P#TWXZ_C7H8?$<_N3W/2PV(Y_<GN5_$?B*19
M)K&PD,1A_P!?./X?]E??M48BN[N$.F[(Q&(=W"'3=GG\TGF2E\LQ/5F.2?<U
MYK=V>6W=G=> -/>."XOW7 DPB>X'7^GY&O1P4&DYL]/ TVDYL[2O0/1"@ H
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M ?Y^_P!*SD[F].'*M3M=4L4U32;S3Y3B.ZA>%CZ!E(_K4[%M75CY8\.W]QX
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B0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140688593629080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Apr. 24, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001854139<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr. 24,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ZEVIA PBC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40630<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">86-2862492<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">15821 Ventura Blvd.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 145<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Encino<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">91436<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(855)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">469-3842<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Class&#160;A common stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ZVIA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>d287617d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="zvia-20220424.xsd" xlink:type="simple"/>
    <context id="duration_2022-04-24_to_2022-04-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001854139</identifier>
        </entity>
        <period>
            <startDate>2022-04-24</startDate>
            <endDate>2022-04-24</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2022-04-24_to_2022-04-24">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2022-04-24_to_2022-04-24"
      id="Hidden_dei_EntityCentralIndexKey">0001854139</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2022-04-24_to_2022-04-24">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2022-04-24_to_2022-04-24">2022-04-24</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2022-04-24_to_2022-04-24">ZEVIA PBC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2022-04-24_to_2022-04-24">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2022-04-24_to_2022-04-24">001-40630</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2022-04-24_to_2022-04-24">86-2862492</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2022-04-24_to_2022-04-24">15821 Ventura Blvd.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2022-04-24_to_2022-04-24">Suite 145</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2022-04-24_to_2022-04-24">Encino</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2022-04-24_to_2022-04-24">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2022-04-24_to_2022-04-24">91436</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2022-04-24_to_2022-04-24">(855)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2022-04-24_to_2022-04-24">469-3842</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2022-04-24_to_2022-04-24">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2022-04-24_to_2022-04-24">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2022-04-24_to_2022-04-24">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2022-04-24_to_2022-04-24">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2022-04-24_to_2022-04-24">Class&#160;A common stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2022-04-24_to_2022-04-24">ZVIA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2022-04-24_to_2022-04-24">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2022-04-24_to_2022-04-24">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="duration_2022-04-24_to_2022-04-24">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M/UY_ 5!+ 0(4 Q0    ( /J6F50'04UB@0   +$    0              "
M 0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ ^I:95':, Z7N
M*P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#
M%     @ ^I:95)E<G",0!@  G"<  !,              ( !S $  'AL+W1H
M96UE+W1H96UE,2YX;6Q02P$"% ,4    " #ZEIE4^H?10FL$  !Y$0  &
M            @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#
M%     @ ^I:95)^@&_"Q @  X@P   T              ( !K@P  'AL+W-T
M>6QE<RYX;6Q02P$"% ,4    " #ZEIE4EXJ[',     3 @  "P
M    @ &*#P  7W)E;',O+G)E;'-02P$"% ,4    " #ZEIE4'#AEZC\!   \
M @  #P              @ %S$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%
M  @ ^I:95"0>FZ*M    ^ $  !H              ( !WQ$  'AL+U]R96QS
M+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ ^I:95&60>9(9 0  SP,
M !,              ( !Q!(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
/  D "0 ^ @  #A0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d287617d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zevia.com//20220424/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d287617d8k.htm">d287617d8k.htm</File>
    <File>d287617dex101.htm</File>
    <File>d287617dex102.htm</File>
    <File>d287617dex103.htm</File>
    <File>d287617dex104.htm</File>
    <File>d287617dex991.htm</File>
    <File>zvia-20220424.xsd</File>
    <File>zvia-20220424_lab.xml</File>
    <File>zvia-20220424_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d287617d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d287617d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "zvia-20220424_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "zvia-20220424_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "zvia-20220424.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd"
     ]
    }
   },
   "elementCount": 25,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 24,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "zvia",
   "nsuri": "http://www.zevia.com/20220424",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d287617d8k.htm",
      "contextRef": "duration_2022-04-24_to_2022-04-24",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.zevia.com//20220424/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d287617d8k.htm",
      "contextRef": "duration_2022-04-24_to_2022-04-24",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zevia.com//20220424/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zevia.com//20220424/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zevia.com//20220424/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zevia.com//20220424/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zevia.com//20220424/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zevia.com//20220424/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zevia.com//20220424/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zevia.com//20220424/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zevia.com//20220424/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zevia.com//20220424/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zevia.com//20220424/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zevia.com//20220424/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zevia.com//20220424/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zevia.com//20220424/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zevia.com//20220424/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zevia.com//20220424/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zevia.com//20220424/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zevia.com//20220424/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zevia.com//20220424/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zevia.com//20220424/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zevia.com//20220424/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zevia.com//20220424/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zevia.com//20220424/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zevia.com//20220424/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001193125-22-118164-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-22-118164-xbrl.zip
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M7J7CTQ7XOZ.F[[J]T[VZIM.3A(M[!>'BTZ+D;+B&,<O CH5<SI>*.&/@819
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M->938A+LV#]L9N7H\D)*SM, ZIX&"J&8"#95?$U8!H9\<PCCF8]+HS<?\<G
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M_C\C?H-]KZ*>?[^H)SC=R=%'7.3_'>2_4$L#!!0    ( /J6F53;J %N[BH
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M?O^G1R]^H>C%-C7'?[A$SVM>R]13-U @%Z$K-WPZC73-_I&1P$>0-.BM<S<
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M:N?@\Q&\O'>P [_LXCJ"O>+F!ON_TYX^CT[$^]$>/'."BX#E#4;[QR?!V@P
M=PX^'>)+L+ =@.QH_X-_AK'Q6 P_'>X=_$[G %/@6R#3/HWV!W:Q[3=@QXU7
M!K W'/G]T<$G_/MHN ?OPA<$A?"@'ZIUTA#T;.RX9HGEZ0"=+,2@#3XV:*GW
M&K2@$-57J?6R!>-Q9QN#9R92=DF/UM["*A5[+8BY_<6E?LH*=(FP0IJEU^5A
M:%^;UJBLOHXEUW3X!<8.UF.R"F'NZP7+H1;H*VLD)(:@BJ[G,DG";./HVBF
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M<HY-6F1"A5 8QJ._G0D)GV=*XS\)_JS'0*<8@4D48(DR,05R$V!;EXX'O=L
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MYTJ5#U\UACG;;+>:QED1N<H&$I.-5LG>X",C0AA\^_#HO/^( IR1E:F04QH
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MJ]>FP1[O\PS_>WD&,)3C@X_XD'_,_?\!4$L#!!0    ( /J6F52Z'.$GZ2H
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M:V_P\%JFPM5>%V6N$E'F$EX:28^ X#ZG,DU)"*-L)A> ?4C?C(V1JVF*A-E
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M2RZBG;K<X '[R/+JC/UG'\#%(W\#4$L! A0#%     @ ^I:95"K=PN A&@
M9I<   X              ( !     &0R.#<V,3=D.&LN:'1M4$L! A0#%
M  @ ^I:95--Z%0*X%   )&0  !$              ( !31H  &0R.#<V,3=D
M97@Q,#$N:'1M4$L! A0#%     @ ^I:95-NH 6[N*@  ]KH  !$
M     ( !-"\  &0R.#<V,3=D97@Q,#(N:'1M4$L! A0#%     @ ^I:95"TB
M07K/$P  TUT  !$              ( !45H  &0R.#<V,3=D97@Q,#,N:'1M
M4$L! A0#%     @ ^I:95+H<X2?I*@  )+L  !$              ( !3VX
M &0R.#<V,3=D97@Q,#0N:'1M4$L! A0#%     @ ^I:95 ^?Z9D"#P  W2\
M !$              ( !9YD  &0R.#<V,3=D97@Y.3$N:'1M4$L! A0#%
M  @ ^I:95(C(#TQ" P  2@L  !$              ( !F*@  'IV:6$M,C R
M,C T,C0N>'-D4$L! A0#%     @ ^I:95"=]? &I!@  I4D  !4
M     ( !":P  'IV:6$M,C R,C T,C1?;&%B+GAM;%!+ 0(4 Q0    ( /J6
MF52VDX?KVP0  /HM   5              "  >6R  !Z=FEA+3(P,C(P-#(T
>7W!R92YX;6Q02P4&      D "0 \ @  \[<

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
